comments_image -

The $200 Billion Colossus

"When I say this is a profitable industry, I mean really profitable. It is difficult to conceive of how awash in money big pharma is."
 
 
LIKE THIS ARTICLE ?
Join our mailing list:

Sign up to stay up to date on the latest headlines via email.

 
 
 
 

The following is taken from Chapter 1 of The Truth About Drug Companies by Marcia Angell, published by Random House.

What does the eight-hundred-pound gorilla do?

Anything it wants to.

What's true of the eight-hundred-pound gorilla is true of the colossus that is the pharmaceutical industry. It is used to doing pretty much what it wants to do. The watershed year was 1980. Before then, it was a good business, but afterward, it was a stupendous one. From 1960 to 1980, prescription drug sales were fairly static as a percent of U.S. gross domestic product, but from 1980 to 2000, they tripled. They now stand at more than $200 billion a year. Furthermore, since the early 1980s, this industry has consistently ranked as the most profitable in the United States˜by a long shot. (Only in 2003 did it fall from that position to rank third among the forty-seven industries listed in the Fortune 500.) Of the many events that contributed to their sudden great and good fortune, none had to do with the quality of the drugs the companies were selling.

In this chapter I'll give you an overview of the pharmaceutical industry – its meteoric rise and the recent, early signs of either a coming fall or an overhaul. I will not go into much detail here; I'll leave that to later chapters. What I want to do now is provide a quick look at what's under this rock when it's lifted. It's not a pretty sight.

Before I begin, a few words about the facts and figures I will use throughout the book. In most cases, I use data from the year 2001, because it is the most recent year for which information is reasonably complete for all the aspects of the industry I will consider. If I stick with one year, it will make it easier to see the whole picture. But for some important facts, I will use figures from 2002 and, whenever possible, 2003. In all cases, I will make it clear what year I am talking about.

I also need to explain what I mean when I say this is a $200 billion industry. According to government sources, that is roughly how much Americans spent on prescription drugs in 2002. That figure refers to direct consumer purchases at drugstores and mail order pharmacies (whether paid for out of pocket or not), and it includes the nearly 25 percent markup for wholesalers, pharmacists, and other middlemen and retailers. But it does not include the large amounts spent for drugs administered in hospitals, nursing homes, or doctors‚ offices (as is the case for many cancer drugs). In most analyses, they are allocated to costs for those facilities.

Drug company revenues (or sales) are a little different, at least as they are reported in summaries of corporate annual reports. They usually refer to a company's worldwide sales, including those to health facilities. But they do not include the revenues of middlemen and retailers.

Perhaps the most quoted source of statistics on the pharmaceutical industry, IMS Health, estimated total worldwide sales for prescription drugs to be about $400 billion in 2002. About half were in the United States. So the $200 billion colossus is really a $400 billion megacolossus, but my focus in this book will be mainly on how the drug companies operate in the United States.

You should understand, however, that it is virtually impossible to be precise about most of these figures. Before drugs reach consumers, they pass through many hands and are paid for in exceedingly complicated, often hidden, ways. It is easy to compare apples and oranges without knowing it. You need to ask, for example, whether a number refers just to prescription drugs or includes over-the-counter drugs and other consumer products made by drug companies; whether it includes revenues for middlemen and retailers or not; whether it refers just to outpatient consumer purchases or also to health facility purchases; and whether it includes mail order purchases.

submit to reddit

-
Email
Print
Share
LIKED THIS ARTICLE? JOIN OUR EMAIL LIST
Stay up to date with the latest AlterNet headlines via email
Alternet Special Coverage - Occupy Wall Street
Advertisement
Most Read
Most Emailed
Most Discussed
On REDDIT
On DIGG
 
loading most read content ..
Advertisement
Wisconsin's Gov. Walker Appeals to CPAC Crowd for Help Fending Off Recall

By Adele M. Stan

 
 
In Birth Control Debate, Cable News Disproportionately Asked Men What They Thought of Women's Health

By Faiz Shakir and Adam Peck | Think Progress

 
 
The Afghanistan Report the Pentagon Doesn't Want You to Read

By Staff | AlterNet

 
 
New Hampshire GOP Reps Offer Bill to Eliminate Lunch Breaks for Workers

By Booman | Booman Tribune

 
 
Montana Ban On Corporate Campaigning Heading To U.S. Supreme Court

By Steven Rosenfeld | AlterNet

 
 
$6.2 Million Settlement for Protesters Arrested at 2003 Iraq War Demonstration

By Staff | AlterNet

 
 
Running Out of Oxygen? Gingrich Loses Crucial Campaign Donor

By Ed Kilgore | Washington Monthly Political Animal

 
 
FBI File Chronicled Steve Jobs' LSD Use

By Hunter R. Slaton | The Fix

 
 
Will Millennials Back Obama in 2012?

By Bill Moyers | BillMoyers.com

 
 
Financial Services Committee Chair Rep. Bachus is Investigated for Insider Trading

By Staff | AlterNet

 
 
 
Reverend Billy Talen
 
 
 
loading ...
POWERED BY DIGG'S USERS
 
[ page served from web 2 ]